Background: Voice and swallowing impairments can impact on both quality of life and survival. Unilateral vocal fold paralysis (UVFP) as a result of distant metastasis can cause breathy voice and aspiration. The purpose of this study is to develop and evaluate a less invasive and effective alternative therapy for UVFP. Methods: This was a retrospective review of prospectively enrolled patients at a tertiary referral center in Taiwan. Among a cohort of 177 patients who received intracordal hyaluronate injections, 2 had UVFP from distant metastasis and met the inclusion criteria. Vocal cord motion was recorded by videostroboscopy, and the normalized glottal gap area was measured. Voice quality, defined by speech language pathologists, and swallowing status were compared, and immediate complications after the injection were investigated. Results: Two patients with UVFP with M1 lesions (both lung) accepted the procedure. The glottal gap area was significantly improved 1 month after in-office hyaluronate injection. Voice quality and aspiration were also improved. No immediate complications were noted in either patient. Conclusions: In-office intracordal hyaluronate injection is a safe and effective treatment for UVFP, providing a palliative method to help maintain the patient's voice and quality of life.

1.
Iseli TA, Brown CL, Sizeland AM, et al: Palliative surgery for neoplastic unilateral vocal cord paralysis. ANZ J Surg 2001;71:672-674.
2.
Morrissey AT, O'Connell DA, Allegratto M: Medialization thyroplasty for unilateral vocal cord paralysis secondary to advanced extralaryngeal malignant disease: review of operative morbidity and patient life expectancy. J Otolaryngol Head Neck Surg 2012;41:41-45.
3.
Mallur PS, Rosen WR: Vocal fold injection: review of indications, techniques, and materials for augmentation. Clin Exp Otorhinolaryngol 2010;3:177-182.
4.
Swibel Rosenthal LH, Michael S, Benninger MS, Deeb RH: Vocal fold immobility: a longitudinal analysis of etiology over 20 years. Laryngoscope 2007;117:1864-1870.
5.
Curtin JP, Malik R, Venkatraman ES, et al: Stage IV ovarian cancer: impact of surgical debulking. Gynecol Oncol 1997;64:9-12.
6.
Su X-D, Zhang D-K, Zhang X, et al: Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis 2014;6:949-957.
7.
Isshiki N, Morita H, Okamura H, Hiramoto M: Thyroplasty as a new phonosurgical technique. Acta Otolarynol 1974;78:451-457.
8.
Vinson KN, Zraick RI, Ragland FJ: Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis. Laryngoscope 2010;120:1802-1807.
9.
Zeitels SM, Casiano RR, Gardner GM, et al: Management of common voice problems: committee report. Otolaryngol Head Neck Surg 2002;126:337-348.
10.
Billante CR, Spector B, Hudson M, et al: Voice outcome following thyroplasty in patients with cancer-related vocal fold paralysis. Auris Nasus Larynx 2001;28:315-321.
11.
Lam PK, Ho WK, Ng ML, Wei WI: Medialization thyroplasty for cancer-related unilateral vocal fold paralysis. Otolaryngol Head Neck Surg 2007;136:440-444.
12.
Lau DP, Lee GA, Wong SM, et al: Injection laryngoplasty with hyaluronic acid for unilateral vocal cord paralysis: randomized controlled trial comparing two different particle sizes. J Voice 2009;24:113-118.
13.
Hertegård S, Hallen L, Laurent C, et al: Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function. Laryngoscope 2002;112:2211-2219.
14.
Pei YC, Fang TJ, Hsin LJ, Li HY, Wong AMK: Early hyaluronate injection improves quality of life but not neural recovery in unilateral vocal fold paralysis: an open-label randomized control study. Restor Neurol Neurosci 2015;33:121-130.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.